Indeed, the gene encoding phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme of the serine biosynthesis pathway, is amplified in breast cancers and melanoma [39,40]. This evidence concerns the gene PHGDH and melanoma.